1999
DOI: 10.1006/abio.1998.3076
|View full text |Cite
|
Sign up to set email alerts
|

Use of Bacteriophage T7 Displayed Peptides for Determination of Monoclonal Antibody Specificity and Biosensor Analysis of the Binding Reaction

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
21
0

Year Published

2000
2000
2007
2007

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 52 publications
(21 citation statements)
references
References 24 publications
0
21
0
Order By: Relevance
“…1999 for interaction analysis has made it possible to obtain affinity and kinetic data for a large Ž number of antigen-antibody Brigham-Burke et al, 1992;VanCott et al, 1994;Oddie et al, 1997;. England et al, 1997;Houshmand et al, 1999, Ž . protein-protein Wu et al, 1995, protein-peptide Ž .…”
mentioning
confidence: 99%
“…1999 for interaction analysis has made it possible to obtain affinity and kinetic data for a large Ž number of antigen-antibody Brigham-Burke et al, 1992;VanCott et al, 1994;Oddie et al, 1997;. England et al, 1997;Houshmand et al, 1999, Ž . protein-protein Wu et al, 1995, protein-peptide Ž .…”
mentioning
confidence: 99%
“…Houshmand et al (5) analyzed the binding and dissociation of 80 nM large T-antigen in solution to the monoclonal antibody, mAbLT1, immobilized on an SPR biosensor surface in the absence and in the presence of competitor peptide, NH 3 -CPNSLTPADPTMDY-COOH. After a time interval the injection of the protein ligand was interrupted, and the dissociation reaction was followed.…”
Section: Resultsmentioning
confidence: 99%
“…Phage display technology was ®rst introduced in the middle of the 80s by Smith using Escherichia coli ®lamentous bacteriophage M13 [Smith, 1985]. Although several alternative phage display systems, such as l-phage, T4 and T7 phage [Santini et al, 1998;Ren and Black, 1998;Houshmand et al, 1999], have been developed for speci®c applications, M13 phage display is still the most robust method particularly applicable to small peptide and antibody engineering [Rader et al, 1998;Schmitz et al, 2000]. Applications of phage display technology in characterization of interactions between peptide ligands and ion-channel receptors have also been reported [Li, 1997].…”
Section: Prokaryotic Systemsmentioning
confidence: 99%